Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

Sequencing Antiangiogenic Agents in Advanced Ovarian Cancer

April 29th 2019

Sequencing PARP Inhibitors in Advanced Ovarian Cancer

April 29th 2019

Prepping Patients With Advanced OC for PARP Inhibition

April 29th 2019

Management of PARP Inhibitor AEs in Ovarian Cancer

April 29th 2019

Impact of SOLO-1 on Advanced Ovarian Cancer Management

April 29th 2019

Advanced OC: Interpreting the Design and Results of SOLO-1

April 29th 2019

PARP Inhibitor Selection in Advanced OC

April 29th 2019

Recurrent Ovarian Cancer: PARP Inhibitor Maintenance Therapy

April 29th 2019

Advanced OC: Clinical Data Behind PARP Inhibition

April 29th 2019

Evolution of PARP Inhibitors in Advanced Ovarian Cancer

April 29th 2019

Comprehensive Review of Maintenance Therapy in Advanced OC

April 29th 2019

Frontline Therapy and Recurrence in Advanced Ovarian Cancer

April 29th 2019

Recommended Approaches to Treating Advanced Ovarian Cancer

April 29th 2019

Advanced Ovarian Cancer: Role of Non-BRCA Mutations

April 29th 2019

Optimizing BRCA Testing in Advanced Ovarian Cancer

April 29th 2019

Role of BRCA Mutations in Advanced Ovarian Cancer

April 29th 2019

Advanced Ovarian Cancer: Evaluating Prognoses

April 29th 2019

Hope Versus Expectation: A Critical Distinction

April 26th 2019

It is critical to inquire what is wrong with hope, if it helps patients through their journey while not interfering with likely necessary end-of-life decisions when these are required to be made.

It's Time to Get Serious About New Rules for Handling Hazardous Drugs

April 23rd 2019

Implementation of new standards for handling hazardous drugs in healthcare facilities is coming closer to reality now that the calendar has flipped to 2019.

CMS' 340B Reform Effort Shakes Up Hospital-Clinic Partnerships

March 29th 2019

Following a multiyear trend in which oncology practices merged with hospitals to achieve savings and improved care, it appeared as though the pendulum was going to swing the other way.